Alessia Grozio
Geriatrics and Gerontology · 2016–2020
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Geriatrics and Gerontology — 36 citations into it
Whom Alessia Grozio trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- S. Imai (in Geriatrics and Gerontology)
Papers from Alessia Grozio's perspective
Ordered by how strongly the researchers Alessia Grozio trusts endorse each paper. Same corpus, a different order for every researcher.
- Mitonuclear protein imbalance as a conserved longevity mechanism (Nature)
- Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice (Cell Metabolism)
- Metformin as a Tool to Target Aging (Cell Metabolism)
- Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. (Cell Metabolism)
- Adipose tissue, inflammation, and cardiovascular disease. (Circulation Research)
- NAD+ metabolism and the control of energy homeostasis - a balancing act between mitochondria and the nucleus (Cell Metabolism)
- NAD+ and Sirtuins in Aging and Disease (Trends in Cell Biology)
- Age Related Changes in NAD+ Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats (PLoS ONE)
- The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells* (Journal of Biological Chemistry)
- Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. (Developmental Cell)
Their papers
- NAD+ metabolism and its roles in cellular processes during ageing (2020) — 1,292 citations
- Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice (2016) — 803 citations